| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 16/12/2024 | 22:05 | Business Wire | GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference | NASDAQ:WGS | GeneDx Holdings Corporation |
| 05/12/2024 | 14:30 | Business Wire | GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners | NASDAQ:WGS | GeneDx Holdings Corporation |
| 22/11/2024 | 22:05 | Business Wire | GeneDx to Participate in Upcoming Investor Conference | NASDAQ:WGS | GeneDx Holdings Corporation |
| 19/11/2024 | 14:30 | Business Wire | GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover | NASDAQ:WGS | GeneDx Holdings Corporation |
| 18/11/2024 | 14:30 | Business Wire | GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary | NASDAQ:WGS | GeneDx Holdings Corporation |
| 07/11/2024 | 22:35 | Business Wire | New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields | NASDAQ:WGS | GeneDx Holdings Corporation |
| 04/11/2024 | 22:35 | Business Wire | GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting | NASDAQ:WGS | GeneDx Holdings Corporation |
| 29/10/2024 | 13:00 | Business Wire | GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights | NASDAQ:WGS | GeneDx Holdings Corporation |
| 24/10/2024 | 17:10 | Business Wire | Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening | NASDAQ:WGS | GeneDx Holdings Corporation |
| 08/10/2024 | 14:30 | Business Wire | GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns | NASDAQ:WGS | GeneDx Holdings Corporation |
| 03/10/2024 | 22:05 | Business Wire | GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024 | NASDAQ:WGS | GeneDx Holdings Corporation |
| 27/09/2024 | 22:05 | Business Wire | GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:WGS | GeneDx Holdings Corporation |
| 04/09/2024 | 03:35 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:WGS | GeneDx Holdings Corporation |
| 12/08/2024 | 22:05 | Business Wire | GeneDx to Participate in Fall Investor Conferences | NASDAQ:WGS | GeneDx Holdings Corporation |
| 31/07/2024 | 22:39 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:WGS | GeneDx Holdings Corporation |
| 30/07/2024 | 22:19 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:WGS | GeneDx Holdings Corporation |
| 30/07/2024 | 22:12 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:WGS | GeneDx Holdings Corporation |
| 30/07/2024 | 22:05 | Business Wire | GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights | NASDAQ:WGS | GeneDx Holdings Corporation |
| 30/07/2024 | 22:05 | Business Wire | GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients | NASDAQ:WGS | GeneDx Holdings Corporation |
| 30/07/2024 | 12:06 | IH Market News | U.S. Futures Climb Before Fed Meeting; Oil Prices Drop on China Demand Worries | NASDAQ:WGS | GeneDx Holdings Corporation |
| 11/07/2024 | 22:05 | GlobeNewswire Inc. | GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024 | NASDAQ:WGS | GeneDx Holdings Corporation |
| 10/06/2024 | 14:30 | GlobeNewswire Inc. | GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients | NASDAQ:WGS | GeneDx Holdings Corporation |
| 05/06/2024 | 13:00 | GlobeNewswire Inc. | GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients | NASDAQ:WGS | GeneDx Holdings Corporation |
| 22/05/2024 | 22:05 | GlobeNewswire Inc. | GeneDx to Participate in Upcoming Investor Conferences | NASDAQ:WGS | GeneDx Holdings Corporation |
| 29/04/2024 | 22:05 | GlobeNewswire Inc. | GeneDx Reports First Quarter 2024 Financial Results and Business Highlights | NASDAQ:WGS | GeneDx Holdings Corporation |
| 23/04/2024 | 14:30 | GlobeNewswire Inc. | GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset | NASDAQ:WGS | GeneDx Holdings Corporation |
| 04/04/2024 | 22:05 | GlobeNewswire Inc. | GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024 | NASDAQ:WGS | GeneDx Holdings Corporation |
| 14/03/2024 | 13:30 | GlobeNewswire Inc. | GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics | NASDAQ:WGS | GeneDx Holdings Corporation |
| 26/02/2024 | 22:05 | GlobeNewswire Inc. | GeneDx to Participate in 44th Annual Cowen Health Care Conference | NASDAQ:WGS | GeneDx Holdings Corporation |
| 23/02/2024 | 22:56 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:WGS | GeneDx Holdings Corporation |